Network-based inference methods for drug repositioning

Computational and Mathematical Methods in Medicine

Volumn 2015, Issue , 2015, Pages

  Chen, Hailin ^a   Zhang, Heng ^a   Zhang, Zuping ^b   Cao, Yiqin ^a   Tang, Wenliang ^a  

^a EAST CHINA JIAOTONG UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TOPOLOGY;

BIOLOGICAL INFORMATION; BIPARTITE NETWORK; COMPREHENSIVE PREDICTION; COMPUTATIONAL STRATEGY; DISEASE ASSOCIATIONS; DRUG REPOSITIONING; PHARMACEUTICAL COMPANY; PREDICTION PERFORMANCE;

FORECASTING;

NEW DRUG; ACETYLSALICYLIC ACID; DRUG; FELODIPINE; TAMOXIFEN;

ARTICLE; DRUG DISEASE ASSOCIATION NETWORK; DRUG INDICATION; DRUG INDUSTRY; DRUG INFORMATION; DRUG REPOSITIONING; MATHEMATICAL AND STATISTICAL PROCEDURES; PREDICTION; ALGORITHM; AREA UNDER THE CURVE; BIOLOGY; CHEMISTRY; COMPUTER SIMULATION; DEVICES; FACTUAL DATABASE; HUMAN; PREDICTIVE VALUE; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; SOFTWARE; STATISTICAL MODEL;

ALGORITHMS; AREA UNDER CURVE; ASPIRIN; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DATABASES, FACTUAL; DRUG REPOSITIONING; FELODIPINE; HUMANS; MODELS, STATISTICAL; PHARMACEUTICAL PREPARATIONS; PREDICTIVE VALUE OF TESTS; ROC CURVE; SOFTWARE; TAMOXIFEN;

EID: 84928753287     PISSN: 1748670X     EISSN: 17486718     Source Type: Journal    
DOI: 10.1155/2015/130620     Document Type: Article

References (36)

1. J. A. DiMasi, "New drug development in the United States from 1963 to 1999, " Clinical Pharmacology and Therapeutics, vol. 69, no. 5, pp. 286-296, 2001.
2. C. P. Adams and V. Van Brantner, "Estimating the cost of new drug development: Is it really $802 million dollars?" Health Affairs, vol. 25, no. 2, pp. 420-428, 2006.
3. B. Booth and R. Zemmel, "Prospects for productivity, " Nature Reviews Drug Discovery, vol. 3, no. 5, pp. 451-456, 2004.
4. L. Brothers, The Fruits of Genomics, Lehman Brothers, New York, NY, USA, 2001.
5. R. Edmunds, P. C. Ma, and C. P. Tanio, "Splicing a cost squeeze into the genomics revolution, " McKinsey Quarterly, vol. 2, pp. 15-18, 2001.
6. I. Vogt and J. Mestres, "Drug-target networks, " Molecular Informatics, vol. 29, no. 1-2, pp. 10-14, 2010.
7. T. T. Ashburn and K. B. Thor, "Drug repositioning: identifying and developing new uses for existing drugs, " Nature Reviews Drug Discovery, vol. 3, no. 8, pp. 673-683, 2004.
8. J. N. Weinstein, T. G. Myers, P. M. O'Connor et al. , "An information-intensive approach to the molecular pharmacology of cancer, " Science, vol. 275, no. 5298, pp. 343-349, 1997.
9. T. Hughes, B. Andrews, and C. Boone, "Old drugs, new tricks: using genetically sensitized yeast to reveal drug targets, " Cell, vol. 116, no. 1, pp. 5-7, 2004.
10. P. Y. Lum, C. D. Armour, S. B. Stepaniants et al. , "Discovering modes of action for therapeutic compounds using a genomewide screen of yeast heterozygotes, " Cell, vol. 116, no. 1, pp. 121-137, 2004.
11. K. E. Kinnamon and W. E. Rothe, "Biological screening in the US Army antimalarial drug development program, " The American Journal of Tropical Medicine andHygiene, vol. 24, no. 2, pp. 174-178, 1975.
12. Y. Yamanishi, M. Araki, A. Gutteridge, W. Honda, andM. Kanehisa, "Prediction of drug-target interaction networks from the integration of chemical and genomic spaces, " Bioinformatics, vol. 24, no. 13, pp. i232-i240, 2008.
13. Y. Yamanishi, M. Kotera, M. Kanehisa, and S. Goto, "Drugtarget interaction prediction fromchemical, genomic and pharmacological data in an integrated framework, " Bioinformatics, vol. 26, no. 12, pp. i246-i254, 2010.
14. Z. Xia, L.-Y. Wu, X. Zhou, and S. T. C. Wong, "Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces, " BMC Systems Biology, vol. 4, supplement 2, article S6, 2010.
15. M. Gönen, "Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization, " Bioinformatics, vol. 28, no. 18, pp. 2304-2310, 2012.
16. X. Chen, M.-X. Liu, and G.-Y. Yan, "Drug-target interaction prediction by random walk on the heterogeneous network, " Molecular BioSystems, vol. 8, no. 7, pp. 1970-1978, 2012.
17. H. Chen and Z. Zhang, "A semi-supervised method for drugtarget interaction prediction with consistency in networks, " PLoS ONE, vol. 8, no. 5, Article ID e62975, 2013.
18. D. Fourches, E. Muratov, and A. Tropsha, "Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research, " Journal of Chemical Information and Modeling, vol. 50, no. 7, pp. 1189-1204, 2010.
19. F. Iorio, R. Bosotti, E. Scacheri et al. , "Discovery of drug mode of action and drug repositioning from transcriptional responses, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14621-14626, 2010.
20. R. L. Chang, L. Xie, P. E. Bourne, and B. E. Palsson, "Drug offtarget effects predicted using structural analysis in the context of a metabolic network model, " PLoS Computational Biology, vol. 6, no. 9, Article ID e1000938, 2010.
21. S. Suthram, J. T. Dudley, A. P. Chiang, R. Chen, T. J. Hastie, and A. J. Butte, "Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets, " PLoS Computational Biology, vol. 6, no. 2, Article ID e1000662, 2010.
22. J. T. Dudley, E. Schadt, M. Sirota, A. J. Butte, and E. Ashley, "Drug discovery in a multidimensional world: systems, patterns, and networks, " Journal of Cardiovascular Translational Research, vol. 3, no. 5, pp. 438-447, 2010.
23. J. T. Dudley, T. Deshpande, and A. J. Butte, "Exploiting drugdisease relationships for computational drug repositioning, " Briefings in Bioinformatics, vol. 12, no. 4, Article ID bbr013, pp. 303-311, 2011.
24. Z. Wu, Y. Wang, and L. Chen, "Network-based drug repositioning, " Molecular BioSystems, vol. 9, no. 6, pp. 1268-1281, 2013.
25. A. P. Davis, C. G. Murphy, R. Johnson et al. , "The comparative toxicogenomics database: update 2013, " Nucleic Acids Research, vol. 41, no. 1, pp. D1104-D1114, 2013.
26. A. P. Chiang and A. J. Butte, "Systematic evaluation of drugdisease relationships to identify leads for novel drug uses, " Clinical Pharmacology andTherapeutics, vol. 86, no. 5, pp. 507-510, 2009.
27. A. Gottlieb, G. Y. Stein, E. Ruppin, and R. Sharan, "PREDICT: a method for inferring novel drug indications with application to personalized medicine, " Molecular Systems Biology, vol. 7, no. 1, article 496, 2011.
28. S. Zhao and S. Li, "A co-module approach for elucidating drug-disease associations and revealing their molecular basis, " Bioinformatics, vol. 28, no. 7, pp. 955-961, 2012.
29. Y.-F. Huang, H.-Y. Yeh, and V.-W. Soo, "Inferring drug-disease associations fromintegration of chemical, genomic and phenotype data using network propagation, " BMCMedical Genomics, vol. 6, supplement 3, article S4, 2013.
30. S. Daminelli, V. J. Haupt, M. Reimann, andM. Schroeder, "Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network, " Integrative Biology, vol. 4, no. 7, pp. 778-788, 2012.
31. H. Ye, L. L. Yang, Z. W. Cao, K. L. Tang, andY. X. Li, "Apathway profile-based method for drug repositioning, " Chinese Science Bulletin, vol. 57, no. 17, pp. 2106-2112, 2012.
32. D. Emig, A. Ivliev, O. Pustovalova et al. , "Drug target prediction and repositioning using an integrated network-based approach, " PLoS ONE, vol. 8, no. 4, Article ID e60618, 2013.
33. T. Zhou, J. Ren, M. Medo, and Y.-C. Zhang, "Bipartite network projection and personal recommendation, " Physical Review E, vol. 76, no. 4, Article ID 046115, 2007.
34. D. S. Wishart, C. Knox, A. C. Guo et al. , "DrugBank: a knowledgebase for drugs, drug actions and drug targets, " Nucleic Acids Research, vol. 36, supplement 1, pp. D901-D906, 2008.
35. A. Hamosh, A. F. Scott, J. Amberger, C. Bocchini, D. Valle, and V. A. McKusick, "Onlined Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders, " Nucleic Acids Research, vol. 30, no. 1, pp. 52-55, 2002.
36. T. Zhoua, Z. Kuscsik, J.-G. Liu, M. Medo, J. R. Wakeling, and Y.-C. Zhang, "Solving the apparent diversity-accuracy dilemma of recommender systems, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 10, pp. 4511-4515, 2010.